DiaMedica Therapeutics Inc. (DMAC) stock

DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30

$9.66−0.01 (-0.10%)

Close on Nov 11, 2026Market cap $520.92MP/E –Yield –

DiaMedica Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

DiaMedica Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?